Author: Alex R. Kulkarni V.
Publisher: Elsevier
ISSN: 0223-5234
Source: European Journal of Medicinal Chemistry, Vol.30, Iss.10, 1995-01, pp. : 815-818
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Pfizer's dual-acting β2 agonists/muscarinic M3 antagonists
By Norman Peter
Expert Opinion on Therapeutic Patents, Vol. 18, Iss. 9, 2008-09 ,pp. :